Godlike Productions - Reply to Thread

Users Online Now: 1,995 (Who's On?)	Visitors Today: 912,528
Pageviews Today: 1,704,315	Threads Today: 832	Posts Today: 14,726
07:00 PM

REPLY TO THREAD

Subject Novavax Likely to Add Fourth COVID Vaccine to U.S. Arsenal

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message Novavax has announced that its coronavirus vaccine was 90.4 percent effective in a large clinical trial, potentially paving the way for its authorization for use in the U.S.

The vaccine showed levels of efficacy similar to the Pfizer-BioNTech and Moderna vaccines, following the trial involving 29,960 people in the U.S. and Mexico. Novavax’s vaccine uses proteins resembling the “spike” proteins on the surface of coronavirus, triggering an immune response in a recipient, in contrast to Pfizer and Moderna which use mRNA technology.

Novavax won a $1.6 billion contract for 100 million doses from the Trump administration’s Operation Warp Speed. The company has never produced a vaccine cleared by regulators in its 33-year history.

[link to www.nationalreview.com (secure)]

[link to www.youtube.com (secure)]

So wonderful! A 90% efficacy rate for a "disease" with a 99.9% survivability rate!

What is wrong with people if they cannot see there is a problem with the numbers?

Pictures (click to insert)





\| Next Page >>